Cargando…

Antithrombotic Therapy in the Prevention of Stroke

Overview: Ischemic stroke is a leading cause of death and disability throughout the world. Antithrombotic therapy, which includes both antiplatelet and anticoagulant agents, is a primary medication of choice for the secondary prevention of stroke. However, the choices vary with the need to incorpora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bir, Shyamal, Kelley, Roger E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698439/ https://www.ncbi.nlm.nih.gov/pubmed/34944719 http://dx.doi.org/10.3390/biomedicines9121906

Ejemplares similares

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
por: Srivastava, Padma
Publicado: (2010)

Carotid atherosclerotic disease: A systematic review of pathogenesis and management
por: Bir, Shyamal C., et al.
Publicado: (2022)

Antithrombotic Medication for Cardioembolic Stroke Prevention
por: Font, M. Àngels, et al.
Publicado: (2011)

Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010)

Covid-19 related stroke: No preventative value of antithrombotic therapy
por: Di Pietro, Martina, et al.
Publicado: (2021)

Antithrombotic Therapy in Patients with Coronary Artery Disease and Prior Stroke
por: Bellettini, Elisa, et al.
Publicado: (2021)

Antithrombotic therapy in TAVI
por: Vavuranakis, Manolis, et al.
Publicado: (2018)

Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review
por: Tornyos, Dániel, et al.
Publicado: (2021)

Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation?
por: Lin, Yi-Pin, et al.
Publicado: (2015)

Antithrombotic therapy in an experimental model of acute ischemic stroke in rabbits
por: Segura, V, et al.
Publicado: (2004)

A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
por: LaHaye, Stephen Andrew, et al.
Publicado: (2012)

Evaluating the Primary Prevention of Ischemic Stroke of Oral Antithrombotic Therapy in Head and Neck Cancer Patients with Radiation Therapy
por: Hsu, Chin-Wei, et al.
Publicado: (2016)

Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update
por: Derex, Laurent, et al.
Publicado: (2018)

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)

Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease
por: Weng, Yunqi, et al.
Publicado: (2017)

Ethnic Differences in Oral Antithrombotic Therapy
por: Cho, Haechan, et al.
Publicado: (2020)

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
por: Kalus, James S
Publicado: (2013)

Monitoring of Antithrombotic Therapy
por: Yamazaki, Masako
Publicado: (2020)

Marine Antithrombotics
por: Dwivedi, Rohini, et al.
Publicado: (2020)

Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome
por: Kefer, Joelle, et al.
Publicado: (2022)

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
por: Husted, Steen
Publicado: (2015)

Timing of Antithrombotic Secondary Prevention in Patients with Intracranial Hemorrhage after Stroke Thrombolysis and Thrombectomy
por: Reale, Giuseppe, et al.
Publicado: (2023)

AMBULATORY EYE SURGERY AND ANTITHROMBOTIC THERAPY – NEW APPROACHES
por: Šimurina, Tatjana, et al.
Publicado: (2021)

Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement
por: Granger, Camille, et al.
Publicado: (2022)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
por: Bonanad, Clara, et al.
Publicado: (2022)

Tutorial in oral antithrombotic therapy: Biology and dental implications
por: Fakhri, Hamid R., et al.
Publicado: (2013)

Antithrombotic Agents and Cancer
por: Bruno, Annalisa, et al.
Publicado: (2018)

Antithrombotic therapy in COVID-19
por: Saeed, Sahrai, et al.
Publicado: (2021)

Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)

Antithrombotic Therapy in Cardiac Embolism
por: Cervera, Álvaro, et al.
Publicado: (2010)

Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization
por: Dreijer, Albert R., et al.
Publicado: (2020)

Update on Antithrombotic Therapy after Percutaneous Coronary Intervention
por: Saito, Yuichi, et al.
Publicado: (2019)

Antithrombotic Therapy after Transcatheter Aortic Valve Replacement
por: Mousa, Tariq A. M., et al.
Publicado: (2022)

Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke
por: García Rodríguez, Luis A., et al.
Publicado: (2022)

Next-generation antithrombotics in ischemic stroke: preclinical perspective on ‘bleeding-free antithrombosis'
por: Kraft, Peter, et al.
Publicado: (2012)

Antithrombotics prescription and adherence among stroke survivors: A systematic review and meta‐analysis
por: Yang, Min, et al.
Publicado: (2022)

Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice
por: Sabir, Ian N, et al.
Publicado: (2013)

Management of antithrombotic therapy during cardiac implantable device surgery
por: AlTurki, Ahmed, et al.
Publicado: (2016)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
por: Bor, Wilbert, et al.
Publicado: (2020)

Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome
por: Towashiraporn, Korakoth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_98mn899n8buth9rkunts60ci9u